SEC Form 4 · accession 0001209191-15-064206

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 3, 2015

Accepted (ET)

Aug 5, 2015 · 7:40 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001088856

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common stock	Jul 22, 2015	G	1,000	$0.00	D	1,578,396	I	James N. Wilson and Pamela D. Wilson Trust
Common stock	Aug 3, 2015	M	3,000	$1.51	A	1,581,396	I	James N. Wilson and Pamela D. Wilson Trust
Common stock^F2	Aug 3, 2015	S	3,000	$4.968	D	1,578,396	I	James N. Wilson and Pamela D. Wilson Trust
Common stock	Aug 4, 2015	M	2,900	$1.51	A	1,581,296	I	James N. Wilson and Pamela D. Wilson Trust
Common stock^F2	Aug 4, 2015	S	2,900	$4.90	D	1,578,396	I	James N. Wilson and Pamela D. Wilson Trust
Common stock	Aug 5, 2015	M	4,100	$1.51	A	1,582,496	I	James N. Wilson and Pamela D. Wilson Trust
Common stock^F2	Aug 5, 2015	S	4,100	$4.90	D	1,578,396	I	James N. Wilson and Pamela D. Wilson Trust
Common stock^F3	Aug 5, 2015	S$0	0	$0.00	D	901,067	I	James and Pamela Wilson Family Partners

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock option^F4	$1.51	Aug 3, 2015	M	3,000	D	—	May 18, 2017	Common stock	3,000	207,000	D
Stock option^F4	$1.51	Aug 4, 2015	M	2,900	D	—	May 18, 2017	Common stock	2,900	204,100	D
Stock option^F4	$1.51	Aug 5, 2015	M	4,100	D	—	May 18, 2017	Common stock	4,100	200,000	D

F1Shares distributed to family members of the Reporting Person.
F2Represents the weighted average sale price for the entire number of shares sold.
F3Not applicable as the line item was included to show all other indirect holdings of the Reporting Person.
F4Fully exerciseable.